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Clinics and pathology 
Disease 
Atypical myeloproliferative disease with eosino-philia 
Epidemiology 
One case to date, a 73-year-old female patient 
(Gallagher et al., 2008). 
Prognosis 
The patient was alive and well after 3 years of therapy 
with imatinib. 
Cytogenetics 
Cytogenetics morphological 
The t(2;5) was the sole anomaly. 
Genes involved and proteins 
SPTBN1 
Location 
2p16.2 is the exact location 
Protein 
SPTBN1 (spectrin beta1 non erythrocytic), also called 
beta-fodrin, is a cytoskeleton protein. Forms dimers 
with alpha-fodrin (SPTAN1, 9q34), which self-
associates head-to-head into tetramers. Mem-brane 
skeleton protein associated with ion channels and 
pumps (Winkelmann and Forget, 1993); Stabilizes cell 
surface membranes; role in mitotic spindles assembly 
(Bennett and Baines, 2001). 
PDGFRB 
Location 
5q33 
Protein 
Comprises an extracellular part with 5 Ig-like C2 type 
domains, a transmembrane domain, and an intracellular 
part with a tyrosine kinase domain (made of two 
tyrosine kinase subdomains) for transduction of the 
signal. Receptor tyrosine kinase; receptor for PDGFB 
and PDGFD (Bergsten et al., 2001); forms 
homodimers, or heterodimer with PDGFRA; upon 
dimerization, subsequent activa-tion by 
autophosphorylation of the tyrosine kinase intracellular 
domains occurs. 
Result of the chromosomal 
anomaly 
Fusion protein 
Description 
Constitutive activation of the PDGFRB tyrosine kinase 
domain. 
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